glycyl-arginyl-glycyl-aspartic acid has been researched along with transforming growth factor beta in 1 studies
| Studies (glycyl-arginyl-glycyl-aspartic acid) | Trials (glycyl-arginyl-glycyl-aspartic acid) | Recent Studies (post-2010) (glycyl-arginyl-glycyl-aspartic acid) | Studies (transforming growth factor beta) | Trials (transforming growth factor beta) | Recent Studies (post-2010) (transforming growth factor beta) |
|---|---|---|---|---|---|
| 14 | 0 | 2 | 49,119 | 560 | 17,610 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, CA; Chen, HC; Guh, JY; Hwang, JC; Tsai, JC | 1 |
1 other study(ies) available for glycyl-arginyl-glycyl-aspartic acid and transforming growth factor beta
| Article | Year |
|---|---|
TGF-beta1 and integrin synergistically facilitate the differentiation of rat podocytes by increasing alpha-smooth muscle actin expression.
Topics: Actins; Animals; Antibodies, Blocking; Cell Count; Cell Differentiation; Cells, Cultured; Dose-Response Relationship, Drug; Drug Combinations; Drug Synergism; Fluorescent Antibody Technique, Indirect; Gene Expression; Genistein; Integrin beta1; Naphthalenes; Oligopeptides; Podocytes; Rats; Rats, Sprague-Dawley; RNA, Messenger; Transforming Growth Factor beta | 2006 |